Deletion in the gene BruAb2_0168 of Brucella abortus strains: diagnostic challenges. by Dean, A S et al.
Deletion in the gene BruAb2_0168 of
Brucella abortus strains: diagnostic
challenges
A. S. Dean1,2, E. Schelling1,2, B. Bonfoh3, A. E. Kulo4,
G. A. Boukaya5 and P. Pilo6
1) Department of Epidemiology and Public Health, Swiss Tropical and Public
Health Institute, 2) University of Basel, Basel, Switzerland, 3) Centre Suisse
de Recherches Scientiﬁques en Coˆte d’Ivoire, Abidjan, Coˆte d’Ivoire, 4) Ecole
Superieure d’Agronomie, Universite de Lome, 5) Direction de l’Elevage,
Ministe`re de l’Agriculture, de l’Elevage et de la Peˆche, Lome, Togo and 6)
Institute for Veterinary Bacteriology, University of Bern, Bern, Switzerland
Abstract
Three Brucella abortus strains were isolated from joint hygromas
from cows in northern Togo. Two deletions in the 5′ side of the
gene BruAb2_0168 were identiﬁed. As this gene is used for
species identiﬁcation, these deletions have consequences for
diagnostic procedures. Multiple locus variable number of tandem
repeat (VNTR) analysis was therefore performed for species
identiﬁcation. The strains showed unique VNTR proﬁles, providing
some of the ﬁrst genotypic data from West Africa. More
molecular and epidemiological data are needed from the region,
in order to better understand transmission patterns and develop
suitable diagnostic assays.
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Although brucellosis is one of the world’s most common
zoonoses, there is a lack of data from sub-Saharan Africa [1,2].
Brucellosis impacts on human and animal health [3] and has
important economic consequences [4]. This report describes
the isolation and genetic characterization of Brucella abortus
strains from Togo, which posed a diagnostic challenge due to
deletions in a gene targeted by PCR and the inability to grow
on selective medium.
During a brucellosis serosurvey in Togo (2011–2012) [5],
joint ﬂuid was aspirated aseptically from nine seropositive
cows from ﬁve herds with hygromas in the carpi/hocks. Sterile
swab tips were soaked in the ﬂuid and sealed in liquid Amies
medium. After storage and transportation at 4°C according to
international biosafety standards, they were cultivated in
Switzerland on tryptic soy agar plates supplemented with 5%
sheep blood (BD, Allschwil, Switzerland) and on Brucella-
medium base agar supplemented with 5% inactivated horse
serum and modiﬁed Brucella selective supplement (Oxoid,
Basingstoke, UK). The plates were incubated for 10 days at
37°C in 5% CO2. All culture manipulations were performed
under Biosafety Level 3 containment. Although there was no
growth on Brucella selective medium, mixed cultures grew on
blood agar. Brucella-like colonies were puriﬁed and isolates
were recovered from three cows from three different herds.
Phenotypic testing of the strains was performed. The strains
did not require CO2 for growth and grew in the presence of
thionin (0.04 mg/mL and 0.02 mg/mL) and basic fuchsine
(0.02 mg/mL). They produced H2S, as detected by hydrogen
sulphide test strips (Sigma Aldrich, Buchs, Switzerland),
and were urease positive (Oxoid). These results indicated
B. abortus biovar 3 [6].
Molecular identiﬁcation of the genus Brucella was performed
by real-time PCR, as previously described [7]. As a spe-
cies-speciﬁc signal for abortus or melitensis could not be
obtained but B. abortus was suspected, it was decided to
amplify a larger DNA segment of the target locus of the
real-time PCR, which was speciﬁc for the species abortus, the
BruAb2_0168 gene (BAbS19_II01580 in vaccine strain S19).
The primer pair used was 0168_Babo_1F and 0168_Babo_1R.
The PCR products were sequenced (primers in Table 1). Two
deletions of 2678 and 263 base pairs were identiﬁed, from
nucleotide positions 984-3662 and 4295-4558 of the sequence
of B. abortus strain S19 (Fig. 1) (GenBank accession number:
KC847095).
The isolated strains displayed features that complicated
diagnosis. Firstly, none grew on Brucella selective medium. As
some B. melitensis and B. abortus strains are sensitive to the
antibiotic concentrations in modiﬁed Brucella selective supple-
ment, it is therefore advisable to concurrently inoculate a
standard growth medium or modiﬁed Thayer-Martin plate [8].
Secondly, the deletions in the BruAb2_0168 gene suggest that
this may not be a suitable target for an abortus species-speciﬁc
PCR. Samples for which a species-speciﬁc signal cannot be
obtained should always be tested for a genus-speciﬁc signal to
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ensure that Brucella sp is not missed. False negatives due to
deletions in targets of diagnostic assays can have important
public health consequences. In Sweden, a deletion of 377 base
pairs in the target of a commercial PCR for the diagnosis of
Chlamydia trachomatis was identiﬁed following a decrease in the
number of human cases detected [9]. Genomes can undergo
modiﬁcations such as deletions, insertions or rearrangements,
and this aspect of bacterial evolution must always be consid-
ered when performing PCR assays for detection and/or
identiﬁcation. Ideally, more than one target should be tested
and unexpected results investigated.
Loci with a variable number of tandem repeats (VNTR) can
be used as markers to identify species belonging to the Brucella
genus (panel 1 markers) and to discriminate among Brucella
strains (panel 2A and 2B markers). Molecular typing by
multiple locus VNTR analysis (MLVA) over 16 loci can be used
as a molecular epidemiology tool to assess brucellosis
transmission patterns [10,11].
MLVA was performed on the three culture lysates and on
B. melitensis strain 16MT. For most loci, sequencing conﬁrmed
the exact PCR product length. However, ﬁve loci could not be
sequenced (bruce06, bruce07, bruce09, bruce30, bruce55) and
their length was determined by comparing the PCR product
bands with those of B. melitensis 16MT on an agarose gel, and by
the Agilent 2100 Bioanalyzer using a DNA 1000 LabChip kit
(Agilent Technologies, Waldbronn, Germany) followed by
comparison with the results of De Santis et al. [12]. The MLVA
data were analysed using the Brucella aggregated database on
MLVAnet (http://mlva.u-psud.fr/) hosted by Universite Paris-
Sud [13]. This database compares queried strains with
described strains and performs a clustering analysis using the
categorical coefﬁcient and unweighted pair group method with
arithmetic mean (UPGMA). The resultant Newick strings were
imported into R statistical software Version 2.12.2 (http://www.
R-project.org) and a dendogram was drawn using the package
‘ape’ (http://ape-package.ird.fr/). The three strains showed
distinct VNTR proﬁles (Table 2) clustering with African strains
of B. abortus biovar 3 (Fig. 2), conﬁrming the phenotypic results.
There is only one other genotyped strain of B. abortus reported
fromWest Africa, isolated from the Gambia [14]. Furthermore,
the three strains were obtained from a small geographical zone,
the sampling sites being only 13–42 km from one another. This
demonstrates the diversity of the circulating strains. Given the
importance of semi-nomadic herd management and cross-
TABLE 1. Primers used for the ampliﬁcation and sequencing
of the BruAb2_0168 gene
Primers Sequences (5′ to 3′)
0168_Babo_1F GGCGTGTATGTTGTTGGTAA
0168_Babo_2F AACATATCGGCGACGCAGTA
0168_Babo_3F GTGACGGGGACGGGTTGGAC
0168_Babo_4F TGCGGATAATAATCTGGGTGA
0168_Babo_5F CGGTTAATGGCACGCTTGAA
0168_Babo_6F CCTCAATGGTGCGTGGGACAA
0168_Babo_7F CGGTTCTGGGTGGCACGGTTA
0168_Babo_8F GCACGGGCAGTCTGACGAAG
0168_Babo_9F GGCGGCACGACGACGGTTGATG
0168_Babo_11F GGATACTGACGGCACGCTTGA
0168_Babo_14F GAACTTCATATCGGTACTGGTG
0168_Babo_15F CTTGGTGATGACAATTCCAAGA
0168_Babo_16F GTCTTTTGTGCTCAAGAACAATC
0168_Babo_17F TGTCGTCAATGGCGGGCGATGGA
0168_Babo_18F GGGAGTGCAGGCAATCACAG
0168_Babo_19F CAGGCACGCTGACGCTGA
0168_Babo_20F ATACACTGACGCTTCAGAACA
0168_Babo_1R ATCGCCACCAACCATCAGC
0168_Babo_2R CGCCGTCAGACTGCCCTCCA
0168_Babo_3R ACCGTCGTTGCGCCCGTA
0168_Babo_4R AAGTGCCGCCGTTAAACGTCA
0168_Babo_5R GTGCCTGTGCCGCTCTTCA
0168_Babo_6R AATTATTCGCCGCATCCTCA
FIG. 1. Location of two deletions in the BruAb2_0168 gene of Brucella abortus strains from Togo compared with B. abortus vaccine strain S19. The
DNA target for the PCR speciﬁc for the abortus species is shown to fall in the range of the ﬁrst deletion.
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border trade in Togo [15], livestock movements are likely to
play a role in this genetic diversity.
In developing countries, culture is often not feasible due to
inadequate laboratory biosafety. At the time of joint ﬂuid
collection, several drops were also added to 1 mL of a
chaotropic lysis buffer [16]. DNA extraction was performed in
Switzerland as previously described [17]. Real-time PCR [7]
conﬁrmed the Brucella genus for six cows, three of which were
culture positive. The use of inactivated, buffered samples is
therefore both safer and more sensitive than culture, and is
recommended for resource-poor, remote areas. Given that
DNA extraction and PCR were performed 10 months after
collection, rapid sample processing is not required.
More molecular data are needed from sub-Saharan Africa, in
order to develop more suitable diagnostic assays for brucel-
losis and better understand the epidemiology of this important
disease. Incoherent diagnostic results should always be further
investigated.
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